Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet
PLAK
1 other identifier
interventional
4
1 country
1
Brief Summary
The purpose of this study is to understand how the reduction in dietary carbohydrates in a very-low carbohydrate ketogenic diet impacts the synthesis of cholesterol, fatty acid, and ketones, and the turnover rate of VLDL and chylomicron particles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2019
CompletedStudy Start
First participant enrolled
March 31, 2019
CompletedFirst Posted
Study publicly available on registry
April 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2019
CompletedNovember 9, 2022
November 1, 2022
18 days
March 29, 2019
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in total cholesterol
Change in serum total cholesterol between Day 3-7 (average value) to Day 17-21 (average value)
Day 3-7 to Day 17-21
Change in low density lipoprotein (LDL) cholesterol
Change in serum LDL cholesterol between Day 3-7 (average value) to Day 17-21 (average value)
Day 3-7 to Day 17-21
Change in high density lipoprotein (HDL) cholesterol
Change in serum HDL cholesterol between Day 3-7 (average value) to Day 17-21 (average value)
Day 3-7 to Day 17-21
Change in apolipoprotein B (apoB) kinetics
Change in apoB turnover rates in LDL and very low density lipoprotein plasma fractions as measured using 2H2 leucine incorporation into apoB and mathematical modeling
Day 3-7 to Day 17-21
Secondary Outcomes (9)
Change in fractional hepatic de novo lipogenesis
Day 3 to Day 17
Change in fractional cholesterol synthesis
Day 3 to Day 17
Change in ketone body synthesis
Day 3 to Day 17
Change in TRL-triglyceride kinetics
Day 3 to Day 17
Change in triglyceride lipolysis
Day 3 to Day 17
- +4 more secondary outcomes
Study Arms (2)
Baseline diet
ACTIVE COMPARATOR1 week baseline diet
Very low carbohydrate diet
EXPERIMENTAL2 week very low carbohydrate ketogenic diet
Interventions
Standard American diet with 50% energy from carbohydrate, 30% from fat, and 20% from protein.
Ketogenic diet with \<50g carbohydrate, 60-75% energy from fat, and 20% from protein
Eligibility Criteria
You may qualify if:
- Male
- years old
You may not qualify if:
- Use of nicotine products
- Has dietary restrictions
- Lactose intolerance
- History of GI disorders, diabetes, liver, kidney, or thyroid disorders
- Taking hypolipidemic, anti-diabetic, anti-hypertensive, or anti-depression medication
- Screening plasma triglyceride \< 50mg/dl or \>500mg/dl
- Screening glucose \> 125mg/dl
- Screening total and LDL-Cholesterol over 95th %tile for age and sex
- BP \> 160/95 mmHg
- Weight loss/gain \> 5% in the previous 3 months (self-reported)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Touro University California
Vallejo, California, 94592, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Grace M Jones, PhD
Touro University, California
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- The nature of the diet does not allow for masking
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2019
First Posted
April 3, 2019
Study Start
March 31, 2019
Primary Completion
April 18, 2019
Study Completion
April 18, 2019
Last Updated
November 9, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share